HopeStage
Back to all studies
RecruitingNCT05994053

EEG-guided brain stimulation for obsessive-compulsive symptoms

About this titleRead the official source — NCT05994053
Device studyAges 18+United StatesOCD
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
90
Sponsor
Boston University Charles River Campus
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT05994053
Official title
Show the full official title

Neuromodulation for a Novel OCD Biomarker and Treatment

Recruitment & locations

Currently recruiting

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston University Charles River Campus, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies